2 completed, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Severe Hypoglycemia: new trials by email Literature Review of Severe Hypoglycemia trials Research Report on Severe Hypoglycemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes VX-880, VX-017 - Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness | Phase 3 | Recruiting | Vertex Pharmaceuticals Incorporated | 57 | 2021-03-29 | 2026-09-01 |
| G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes G-Pen, Novo Glucagon - Insulin Hypoglycemia, Type 1 Diabetes Mellitus | Phase 3 | Completed | Xeris Pharmaceuticals | 132 | 2018-09-27 | 2020-05-22 |
| G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes G-Pen, Lilly Glucagon - Insulin Hypoglycemia, Type 1 Diabetes Mellitus | Phase 3 | Completed | Xeris Pharmaceuticals | 81 | 2018-01-23 | 2020-02-17 |
Diabetes Mellitus, Type 1 (3) · Hypoglycemia (3)
Autoimmune Diseases (3) · Diabetes Mellitus (3) · Endocrine System Diseases (3) · Glucose Metabolism Disorders (3) · Immune System Diseases (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3)
Glucagon (2)
Xeris Pharmaceuticals (2) · Vertex Pharmaceuticals Incorporated (1)
Canada (3) · United States (3) · Austria (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Norway (1) · Saudi Arabia (1) · Switzerland (1) · United Kingdom (1)